Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

呋喃妥因肠溶片 - NMPA Drug Approval Details

Approvals/NMPA/Nitrofurantoin Enteric-coated Tablets

Approved

化学药品

Nitrofurantoin Enteric-coated Tablets

许昌未来制药有限责任公司🇨🇳 National Medical Products Administration

Approval Date: Dec 17, 2021
Approval ID: 7LeaeyUPX0T
Company: 许昌未来制药有限责任公司
Type: 化学药品

Approval Details

Approval Id: 7LeaeyUPX0T
Approval Number: 国药准字H41022662
Generic Name: 呋喃妥因肠溶片
Generic Name En: Nitrofurantoin Enteric-coated Tablets
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 50mg
Reg Date: 2021-12-17
Company Name: 许昌未来制药有限责任公司
Company Address: 许昌市东城区许由东路3888号
Production Company Name: 许昌未来制药有限责任公司
Production Company Address: 许昌市东城区许由东路3888号
Company Detail Path: /organization/5a214918301885e4/xu-chang-wei-lai-zhi-yao-you-xian-ze-ren-gong-si
Production Company Detail Path: /organization/5a214918301885e4/xu-chang-wei-lai-zhi-yao-you-xian-ze-ren-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 17, 2021

Approval ID

7LeaeyUPX0T

Type

化学药品

Back to NMPA Approvals